Duoning Biotechnology
PrivateLast Round
Private Equity
Mar 1, 2023
Est. Valuation
$1.46B
Total Funding Raised
$16.34M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Duoning Biotechnology is a biotechnology company that provides comprehensive solutions for the research, development, and commercialization of biologics products, offering a wide range of reagents, consumables, and equipment to support bioprocess and laboratory R&D.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Pharma Supply Chain, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Duoning Biotechnology Comparables
Compare Duoning Biotechnology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Suzhou Womei Biology Co., Ltd. | 84% | |
| Sartorius Aktiengesellschaft | 80% | |
| Cobetter Filtration | 79% |
Duoning Biotechnology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Equity | Mar 1, 2023 | ||||
| Series C | Nov 24, 2021 | ||||
| Series B | Dec 30, 2020 | ||||
| Series A Extension | Apr 24, 2019 | ||||
| Series A | Sep 29, 2018 |
Duoning Biotechnology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Huitianfu Fund Management Co., Ltd. | Series C |
| Lake Bleu Capital | Series C, Series B |
| GL Capital Group | Series C |
| Ally Bridge Group | Series A Extension |
| HongShan Capital Group (HSG) | Series C, Series B |
| China Asset Management Co., Ltd. | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 47% MoM.
- Apr 17, 2026
Monthly visitors increased 189% MoM.
Duoning Biotechnology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Duoning Biotechnology's valuation, stock price, and market status.
Is Duoning Biotechnology a public or private company?
Duoning Biotechnology is a private company.
What is the current stock price of Duoning Biotechnology?
Duoning Biotechnology is a private company with no public stock price. No recent secondary market data is available.
How much is Duoning Biotechnology worth (valuation)?
Duoning Biotechnology's valuation is estimated at $46.6M based on funding round data.
Can I buy Duoning Biotechnology stock?
Duoning Biotechnology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Duoning Biotechnology's last funding round?
Duoning Biotechnology's most recent funding round was Series C on September 29, 2018.
Who are the main investors in Duoning Biotechnology?
Key investors in Duoning Biotechnology include Huitianfu Fund Management Co., Ltd., Lake Bleu Capital, Ally Bridge Group, HongShan.
Will Duoning Biotechnology IPO soon?
No public IPO plans have been announced for Duoning Biotechnology.
How can I track Duoning Biotechnology secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Duoning Biotechnology's secondary market activity and sign up for updates.